Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$89.6M
-16.9% from 2023
Prescriptions
130K
$690.64 per claim
Patients
18K
13,907 prescribers
Total spending, 2024
$89.6M
$4,919.43 per patient
Medicare prescription drug plans paid $89.6M for Namzaric in 2024, for 129,746 prescriptions and refills to 18,215 patients (down 16.9% from 2023). The average cost per claim was $690.64.
New York had the highest Medicare cost for Namzaric in 2024: $14.7M for 22,470 claims, followed by California ($12.8M).
Alexander Pinkusovich, psychiatry in Brooklyn, NY, had the highest Medicare cost for Namzaric in 2024: 1,896 claims costing $1.1M.
Namzaric is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Allergan Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Alexander Pinkusovich Brooklyn, NY | Psychiatry | 1,896 | 248 | $1.1M |
| Inna Markhasina Brooklyn, NY | Psychiatry | 672 | 91 | $373K |
| Tsilya Bass West Hollywood, CA |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 20,568 | 204,302 | 29,184 | $134.1M |
| 2023 | 16,206 | 151,212 | 21,595 | $107.8M |
| 2024 | 13,907 | 129,746 | 18,215 | $89.6M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Psychiatry |
| 496 |
| 63 |
| $295K |
| Victor H Salazar-Calderon Phoenix, AZ | Neurology | 148 | 51 | $245K |
| Tatyana P Tsipursky Brooklyn, NY | Psychiatry | 397 | 47 | $233K |
| Jonathan J Eskenazi Beverly Hills, CA | Neurology | 355 | 74 | $223K |
| Marina Neystat Forest Hills, NY | Neurology | 328 | 49 | $207K |
| Annais Troncoso Imperial, CA | Nurse Practitioner | 270 | 65 | $192K |
| Manvel M Mazmanyan Glendale, CA | General Practice | 297 | 36 | $187K |
| Bradford Frank San Diego, CA | Psychiatry | 591 | 47 | $183K |
| Laura Amram Forest Hills, NY | Psychiatry | 311 | 38 | $176K |
| Nivea R Ribas Miami Lakes, FL | Neurology | 220 | 34 | $173K |
| Mario A Lopez Esqueda Brawley, CA | Nurse Practitioner | 239 | 59 | $158K |
| Nagesh B Krish Union City, NJ | Neurology | 127 | 30 | $153K |
| Gennadiy Goldvekht Brooklyn, NY | Nurse Practitioner | 269 | 34 | $152K |
| Isak Isakov Forest Hills, NY | Psychiatry | 266 | 33 | $148K |
| Ivan Mikolaenko Coral Springs, FL | Critical Care (Intensivists) | 241 | 52 | $148K |
| Charles F Asta Teaneck, NJ | Neurology | 124 | 30 | $144K |
| Oksana Levitansky Brooklyn, NY | Internal Medicine | 236 | 25 | $134K |
| Vadim Azbel Staten Island, NY | Psychiatry | 238 | 23 | $133K |
| Margarita Fuzaylova Rego Park, NY | Psychiatry | 223 | 25 | $129K |
| Elvira Kamenetsky Brooklyn, NY | Neurology | 207 | 24 | $125K |
| Geoffrey A Mire Lafayette, LA | Family Practice | 408 | 20 | $121K |
| Mary A Tran Garden Grove, CA | Family Practice | 172 | 24 | $119K |
| Jose A Gonzalez Hialeah, FL | General Practice | 136 | 26 | $119K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Allergan Inc. ABBV | 129,758 | $89.6M |